[PDF][PDF] Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial

…, C Bighin, JGM Klijn, FT Ageev… - Journal of clinical …, 2007 - iris.unina.it
… However, trastuzumab treatment is also associated with congestive heart failure and cardiac
dysfunction.In the Herceptin Adjuvant (HERA) trial, we therefore prospectively monitored …

Prognostic value of changes in arterial stiffness in men with coronary artery disease

…, EY Nuraliev, EB Yarovaya, FT Ageev - Vascular health and risk …, 2010 - Taylor & Francis
Background Men with coronary artery disease (CAD) have been shown to have enhanced
arterial stiffness. Arterial function may change over time according to treatment, but the …

[HTML][HTML] Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial

…, YM Lopatin, AS Ametov, FT Ageev… - Terapevticheskii …, 2021 - ter-arkhiv.ru
At an international online expert meeting held on September 16, 2021, the results of the
empagliflozin research program EMPA-REG Outcome, EMPEROR-Reduced and EMPEROR-…

Early diagnostics and prevention of anthracycline-induced cardiomyopathy–the role of cardiologist

IE Chazova, AG Ovchinnikov, FT Ageev - OncoReview, 2015 - journalsmededu.pl
Anticancer antibiotics, anthracyclines, may cause severe left ventricle systolic dysfunction
that is associated with poor clinical prognosis. In this review, we discuss the mechanisms and …

[HTML][HTML] … heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) and …

VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
… ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The
… diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal …

[HTML][HTML] Use of Digital Technology Tools to Characterize Adherence to Prescription-Grade Omega-3 Polyunsaturated Fatty Acid Therapy in Postmyocardial or …

GP Arutyunov, AG Arutyunov, FT Ageev, TV Fofanova - JMIR cardio, 2022 - cardio.jmir.org
Background Maintaining sustained adherence to medication for optimal management of
chronic noninfectious diseases, such as atherosclerotic vascular disease, is a well-documented …

[HTML][HTML] Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study

…, IV Fomin, YN Belenkov, VY Mareev, FT Ageev… - Kardiologiia, 2021 - lib.ossn.ru
… Effects of structured heart failure disease management on mortality and morbidity depend
on patients’ mood: results from the Interdisciplinary Network for Heart Failure Study: Effects of …

Diastolic heart failure: 20 years later. Сurrent issues of pathoge-nesis, diagnosis and treatment of heart failure with preserved LVEF

FT Ageev, AG Ovchinnikov - Kardiologiia, 2023 - europepmc.org
… , And treatment of heart failure with preserved LV EFThis … , and treatments of heart failure
with preserved ejection fraction (… the structure of causes for chronic heart failure (CHF), such as …

[HTML][HTML] Digital technology tools to examine patient adherence to a prescription-only omega-3 polyunsaturated fatty acid therapy to mitigate cardiovascular risk …

GP Arutyunov, AG Arutyunov, FT Ageev… - JMIR Research …, 2021 - researchprotocols.org
Background Sustained adherence and persistence with prescription medications is
considered essential to achieve maximal treatment benefit for patients with major chronic, …

[HTML][HTML] The molecular and cellular mechanisms associated with a microvascular inflammation in the pathogenesis of heart failure with preserved ejection fraction

…, AV Potekhina, AY Filatova, FT Ageev… - Acta Naturae …, 2020 - cyberleninka.ru
… Heart failurefailure with reduced ejection fraction proved ineffective in HFpEF, which was
probably due to the different mechanisms of development of these two types of heart failure